Rassu, Mauro Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype. [electronic resource] - Journal of cellular and molecular medicine 12 2019 - 8505-8510 p. digital Publication Type: Journal Article; Research Support, Non-U.S. Gov't ISSN: 1582-4934 Standard No.: 10.1111/jcmm.14674 doi Subjects--Topical Terms: AnimalsAnticonvulsants--pharmacologyCell Line, TumorCells, CulturedEpilepsy--drug therapyLeucine-Rich Repeat Serine-Threonine Protein Kinase-2--geneticsLevetiracetam--pharmacologyMembrane Glycoproteins--metabolismMice, Inbred C57BLMice, KnockoutMice, TransgenicMutationNerve Tissue Proteins--metabolismNeurites--drug effectsNeurons--drug effectsPC12 CellsParkinson Disease--drug therapyProtein BindingRatsSignal Transduction--drug effectsSynaptic Vesicles--metabolism